Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Esophageal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT03740256
What this trial is testing

Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors

Who this might be right for
Bladder CancerHead and Neck Squamous Cell CarcinomaCancer of the Salivary Gland+7 more
Baylor College of Medicine 45
Early research (Phase 1)Active Not RecruitingNCT05544929
What this trial is testing

Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

Who this might be right for
Carcinoma, Non-Small-Cell LungCutaneous MelanomaCarcinoma, Renal Cell+9 more
Novartis Pharmaceuticals 126
Early research (Phase 1)Looking for participantsNCT05208762
What this trial is testing

PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungSquamous Cell Carcinoma of the Head and NeckEsophageal Squamous Cell Carcinoma+5 more
Seagen, a wholly owned subsidiary of Pfizer 714
Early research (Phase 1)Ended earlyNCT03680560
What this trial is testing

Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor Cancers

Who this might be right for
Solid TumorHER-2 Protein Overexpression
Cogent Biosciences, Inc. 6
Testing effectiveness (Phase 2)Study completedNCT00020761
What this trial is testing

Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
Jonsson Comprehensive Cancer Center 51
Testing effectiveness (Phase 2)UnknownNCT00003326
What this trial is testing

Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Theradex 100
Testing effectiveness (Phase 2)WithdrawnNCT03307941
What this trial is testing

Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Jction CA

Who this might be right for
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionSquamous Cell Carcinoma of the Esophagus
Jules Bordet Institute
Not applicableStudy completedNCT04449679
What this trial is testing

Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study

Who this might be right for
Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage 0 Gastric Cancer AJCC v8+83 more
Thomas Jefferson University 34
Early research (Phase 1)Not Yet RecruitingNCT07643727
What this trial is testing

Development of Fluorescent Lectin Tracers With Dedicated Technology for in Vivo Detection of Esophageal Dysplasia in Barrett Patients

Who this might be right for
Barrett's Esophagus With or Without DysplasiaBarrett Esophagus Adenocarcinoma
University Medical Center Groningen 49
Testing effectiveness (Phase 2)UnknownNCT02018367
What this trial is testing

Accuracy, Yield and Clinical Impact of a Low-Cost HRME in the Early Diagnosis of Esophageal Adenocarcinoma

Who this might be right for
Barrett's Esophagus
Anandasabapathy, Sharmila, M.D. 100
Testing effectiveness (Phase 2)Study completedNCT00390416
What this trial is testing

Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma

Who this might be right for
Stomach NeoplasmsEsophageal Neoplasms
Memorial Sloan Kettering Cancer Center 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT06914687
What this trial is testing

Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaPeritoneal Metastasis
Fudan University 30
Testing effectiveness (Phase 2)Study completedNCT03196232
What this trial is testing

Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaRecurrent Esophageal Carcinoma+4 more
George Albert Fisher 3
Not applicableUnknownNCT04189393
What this trial is testing

Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal Surgery

Who this might be right for
Gastrointestinal CancerColorectal CancerPancreatic Cancer+8 more
Radboud University Medical Center 60
Early research (Phase 1)Active Not RecruitingNCT05075993
What this trial is testing

Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

Who this might be right for
Metastatic EsophagealGastric CancerMetastatic Head and Neck Carcinoma+5 more
M.D. Anderson Cancer Center 352
Early research (Phase 1)Looking for participantsNCT07059299
What this trial is testing

A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma

Who this might be right for
Esophagogastric Junction AdenocarcinomaGastric AdenocarcinomaEsophageal Adenocarcinoma+2 more
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 18
Not applicableUnknownNCT06550063
What this trial is testing

HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological Outcomes

Who this might be right for
Esophagus CancerGastric CancerHER2-positive Cancer+1 more
St. James's Hospital, Ireland 2,188
Testing effectiveness (Phase 2)Study completedNCT00017056
What this trial is testing

BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT06126406
What this trial is testing

Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerRectal Cancer+5 more
Chongqing Precision Biotech Co., Ltd 60
Testing effectiveness (Phase 2)UnknownNCT02915432
What this trial is testing

The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC

Who this might be right for
Gastric AdenocarcinomaEsophageal Squamous Cell CarcinomaNasopharyngeal Carcinoma+1 more
Shanghai Junshi Bioscience Co., Ltd. 401
Next Page